Lung Neoplasm Clinical Trial
Official title:
Feasibility Study of Anatomical Modeling for Image Guided Thoracic Surgery
Verified date | February 2024 |
Source | M.D. Anderson Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This clinical trial assesses the feasibility of creating a 3 dimensional (D) model of the lung and lung nodule(s) from computed tomography (CT) scan images performed during lung surgery. Unlike solid organs (like the kidney, brain, and liver), the lung changes shape (they inflate when a person breathe in and collapse when they breathe out). This makes it difficult to predict where, exactly, the tumor(s) will be on the lungs during surgery. A 3D model may help surgeons better predict where the location of the tumor(s) will be during surgery.
Status | Recruiting |
Enrollment | 10 |
Est. completion date | April 30, 2025 |
Est. primary completion date | April 30, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients must have previous CT images demonstrating a lung mass or masses amenable to lung resection (open or minimally invasive) - Patient is scheduled for surgical resection in a room equipped with intraoperative CT - Patient must sign informed consent, with risks and benefits of CT imaging explained - Patients with lung tumors >= 1cm to =< 3 cm based on preoperative CT scan. (Patients with lung tumors from < 1 cm or > 3 cm will be reviewed and approved for inclusion on an individual assessment by clinical collaborators) Exclusion Criteria: - Pediatric patients less than 18 years of age - Patients who have undergone previous ipsilateral thoracic surgery, sclerotherapy, or radiation therapy as intraoperative adhesions may limit lung collapse intraoperatively - Patients who received neoadjuvant immunotherapy - Women who are pregnant or nursing |
Country | Name | City | State |
---|---|---|---|
United States | M D Anderson Cancer Center | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
M.D. Anderson Cancer Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of anatomical modeling for image guided thoracic surgery | The geometrical accuracy of the models for localizing the tumor will be quantified. The study is feasible if tumors for all 10 patients can be located with accuracy of within 1 cm or less. Anatomical modeling for image guided thoracic surgery will be considered feasible if researchers are able to determine the location of the tumor in a deflated lung to within the accuracy required by the surgeon for clinical use. | Up to 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Completed |
NCT04508270 -
Significance of Early Mobilization After VATS-L
|
||
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Completed |
NCT05469425 -
Home-based Preoperative Exercise Training for Lung Cancer Patients Undergoing Surgery
|
N/A | |
Terminated |
NCT03090880 -
Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)
|
Phase 3 | |
Recruiting |
NCT05596760 -
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers
|
N/A | |
Completed |
NCT02498860 -
Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung
|
Phase 2 | |
Completed |
NCT02952261 -
Application of 3D Printing Technique in Small Pulmonary Nodule Localization
|
N/A | |
Not yet recruiting |
NCT06024538 -
Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies
|
||
Recruiting |
NCT02965300 -
The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis
|
N/A | |
Completed |
NCT02616211 -
An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors
|
||
Recruiting |
NCT00765986 -
Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy
|
N/A | |
Completed |
NCT03320044 -
Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing
|
||
Recruiting |
NCT03655015 -
Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
|
||
Completed |
NCT03741868 -
Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients Undergoing First or Second Line Immunotherapy
|
||
Not yet recruiting |
NCT05179408 -
Telerehabilitation Following Lung Cancer
|
N/A | |
Completed |
NCT03749512 -
NLCR in Prediction of the Grade of Lung Tumor.
|
||
Recruiting |
NCT03664843 -
Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients
|
||
Completed |
NCT01261507 -
Reader Study of DeltaView™ Chest Radiograph Software
|
N/A | |
Terminated |
NCT01064050 -
Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers
|
Phase 4 |